HALOZYME THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Halozyme Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$489K, a 99.7% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$408M, a 213% decline from 2022.
  • Halozyme Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $362M, a 365% increase from 2021.
  • Halozyme Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $77.9M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$408M -$770M -213% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $362M +$285M +365% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $77.9M +$184M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$106M -$259M -169% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $153M +$217M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$63.8M -$195M -148% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $132M -$19M -12.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $151M +$138M +1050% Jan 1, 2016 Dec 31, 2016 10-K 2017-02-28
2015 $13.1M -$101M -88.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-28
2014 $115M +$89.4M +357% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $25.1M -$87.8M -77.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $113M +$108M +2276% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $4.75M -$57.1M -92.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $61.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.